| Product Code: ETC9965334 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States saw a shift in the enteral collagen peptide import market in 2024, with increased concentration among top exporting countries such as Canada, China, Netherlands, Egypt, and the UK. Despite a negative compound annual growth rate (CAGR) from 2020-2024 and a decline in growth rate from 2023-2024, the market remains dynamic. The rise in Herfindahl-Hirschman Index (HHI) indicates higher concentration, potentially leading to increased competition and strategic partnerships within the industry. Monitoring these trends will be crucial for stakeholders navigating the evolving landscape of enteral collagen peptide imports in the US.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Enteral Collagen Peptide Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Enteral Collagen Peptide Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Enteral Collagen Peptide Market - Industry Life Cycle |
3.4 United States (US) Enteral Collagen Peptide Market - Porter's Five Forces |
3.5 United States (US) Enteral Collagen Peptide Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 United States (US) Enteral Collagen Peptide Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.7 United States (US) Enteral Collagen Peptide Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 United States (US) Enteral Collagen Peptide Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing consumer awareness about the health benefits of collagen supplements |
4.2.2 Increasing demand for natural and clean label ingredients in functional foods and beverages |
4.2.3 Rise in the aging population seeking products for joint health and skin rejuvenation |
4.3 Market Restraints |
4.3.1 High cost associated with premium quality collagen peptides |
4.3.2 Limited availability of collagen sources leading to supply chain constraints |
4.3.3 Regulatory challenges related to health claims and labeling of collagen products |
5 United States (US) Enteral Collagen Peptide Market Trends |
6 United States (US) Enteral Collagen Peptide Market, By Types |
6.1 United States (US) Enteral Collagen Peptide Market, By Form |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Form, 2021- 2031F |
6.1.3 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Powder, 2021- 2031F |
6.1.4 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Liquid, 2021- 2031F |
6.1.6 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Type, 2021- 2031F |
6.1.7 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Pump-type, 2021- 2031F |
6.1.8 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Gravity-type, 2021- 2031F |
6.2 United States (US) Enteral Collagen Peptide Market, By Age Group |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Adults (Above 18), 2021- 2031F |
6.2.3 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Pediatrics (Below 18), 2021- 2031F |
6.2.5 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Application, 2021- 2031F |
6.2.6 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.7 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Home Treatment, 2021- 2031F |
6.3 United States (US) Enteral Collagen Peptide Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.3.3 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 United States (US) Enteral Collagen Peptide Market Revenues & Volume, By Nursing Home, 2021- 2031F |
7 United States (US) Enteral Collagen Peptide Market Import-Export Trade Statistics |
7.1 United States (US) Enteral Collagen Peptide Market Export to Major Countries |
7.2 United States (US) Enteral Collagen Peptide Market Imports from Major Countries |
8 United States (US) Enteral Collagen Peptide Market Key Performance Indicators |
8.1 Consumer satisfaction and loyalty metrics for enteral collagen peptide products |
8.2 Percentage of market share held by enteral collagen peptide products in the overall nutraceuticals market |
8.3 Number of clinical studies supporting the efficacy and safety of enteral collagen peptide products |
9 United States (US) Enteral Collagen Peptide Market - Opportunity Assessment |
9.1 United States (US) Enteral Collagen Peptide Market Opportunity Assessment, By Form, 2021 & 2031F |
9.2 United States (US) Enteral Collagen Peptide Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.3 United States (US) Enteral Collagen Peptide Market Opportunity Assessment, By End user, 2021 & 2031F |
10 United States (US) Enteral Collagen Peptide Market - Competitive Landscape |
10.1 United States (US) Enteral Collagen Peptide Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Enteral Collagen Peptide Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |